New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → News Desk 2018 Nov 16, 2017 at 5:00 PM 99 Regen Biopharma, Inc. (RGBP: OTCQB) | Regen BioPharma Inc. Chairman Discusses the Rationale for Pursuing Autoimmune Indications by Activating the Nuclear Receptor NR2F6 Newer Older
